Innovation Park Basel Area

Innovation Log


The Park Basel Area community is growing – we are delighted to present our new residents.

The portfolio of drug discovery companies working on their research ideas at the equipped shared laboratory space of Switzerland Innovation Park Basel Area is growing. In May 2018, Skyhawk Therapeutics, a Boston-based company, moved in to perform some of its research activities focusing on a novel platform to develop small molecules targeting RNA.

Alibion, a biotech company focused on accelerating the development of therapeutics through early stages, joined our office space. The team identifies promising novel therapeutics from academic laboratories and pools the necessary resources to drive these compounds out of the labs and into late-stage development.

With Pharmaprint LLC, the park’s competences in 3-D printing develop. The company is working on innovative 3-D printing methods with the ambition of changing the worldwide production of pharmaceuticals.

Finally, a specialist in securing financing for ambitious R&D projects has moved in. Catalyze supports researchers and companies in securing financing, from early stage pre-clinical research up to clinical stage development.

Find out more about our residents here.

Leave a Comment:

«You may also like»

View of Switzerland Innovation Park Basel Area in Allschwil

Allschwil – Birthplace of ground-breaking life sciences companies

Located in the midst of the Life Sciences Cluster Basel, Allschwil is a great location for…> Read more

Register for the DBE Research Day 2018

On September 5, 2018, the Department of Biomedical Engineering (DBE) is open to the public. Guests,…> Read more
Predemtec at Switzerland Innovation Park Basel Area is focused on research, development and manufacture of innovative diagnostic tests for use in the detection of Alzheimer-related risk factors

Early Diagnosis for Alzheimer’s Disease

Despite all efforts, science has not yet found an effective way to treat Alzheimer's disease. Predemtec…> Read more